Yaling Hu
No. 85, Jiefang South Road
Taiyuan, 030001, China
Taiyuan, 030001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Astragaloside IV ameliorates diabetic kidney disease by modulating the PHD2/HIF-1α axis and inhibiting podocyte ferroptosis.
Journal: Biochemical pharmacology
Published: May 13, 2026
Astragaloside IV alleviates renal fibrosis by inhibiting renal tubular epithelial cell pyroptosis induced by urotensin II through regulating the cAMP/PKA signaling pathway.
Journal: PloS one
Published: November 15, 2023
Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α Axis.
Journal: DNA and cell biology
Published: September 26, 2023
Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: April 10, 2022
Study on the Mechanism of Radix Astragali against Renal Aging Based on Network Pharmacology.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: November 28, 2021
Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: November 25, 2021
Bioinformatics analysis of genes related to iron death in diabetic nephropathy through network and pathway levels based approaches.
Journal: PloS one
Published: August 17, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026